The FASTER Act of 2026 (HR 9988) amends the Federal Food, Drug, and Cosmetic Act to designate barley, rye, and oats as major food allergens alongside wheat, which will collectively be labeled as "gluten-containing grains." The bill requires stricter labeling requirements for foods containing these grains, mandates FDA compliance guidance updates within one year, and applies these rules to foods introduced into commerce one year after enactment. Additionally, the bill requires the Secretary of Health and Human Services to submit a comprehensive report to Congress within one year documenting current knowledge gaps, research needs, and treatment developments related to Celiac disease and gluten sensitivity.

Why It Matters to MAHA

This bill directly advances MAHA's core commitment to transparency and patient autonomy by ensuring consumers have clear, accurate information about potential allergens in food products. The expanded labeling requirements empower individuals with food allergies and Celiac disease to make informed dietary choices without relying on fragmented or unclear labeling systems. By mandating research into Celiac disease prevalence, diagnostic tools, and emerging treatments, the bill supports access to innovative health solutions and evidence-based patient care. The bipartisan sponsorship reflects broad recognition that food safety transparency serves all Americans regardless of political affiliation. This is fundamental health freedom work that removes information barriers and enables patients to protect their own health.